With the recent approval of Bitcoin [BTC] ETFs, attention has now shifted to the possibility of an Ethereum [ETH] ETF.
However, unlike its counterpart, the path to approval for ETH ETFs remains uncertain, leaving the market speculating about a potential timeline.
Adding to the intrigue, SEC Chair Gary Gensler has offered no clear indication of whether the commission will approve a spot Ether ETF anytime soon.
In a recent interview with Yahoo Finance, Gensler avoided directly addressing the question, opting not to prejudge any filings.
He noted,
“I don’t want to prejudge anyone filing, and as you said, there are ten filings in front of us.”
He further added,
“So, news alert, I’m not going to prejudge that. But to your question, we look at the facts and circumstances and that which was in front of us.”
Will ETH ETF receive similar validation?
Amidst the anticipation surrounding the approval of an Ethereum ETF, major players like BlackRock and Fidelity are already vying for a spot in the market.
Despite optimism fueled by the presence of ether futures ETFs and Grayscale’s past success against the SEC, Bloomberg’s senior analyst Eric Balchunas warns that the SEC’s silence could signal potential hurdles.
“Normally I’d say this was good sign but as far as I know the Staff has not given any comments yet to the issuers, which is not a good sign as we past when they gave comments on btc ETFs.”
Notably, while Gensler remained ambiguous about the ETH ETF approval, his disapproval of the crypto industry was evident, despite his role in the recent Bitcoin ETF vote.
The future of ETFs
In the interview, Gensler criticized the crypto industry for widespread fraud and abuse, pointing to recent bankruptcies.
He slammed intermediaries for not disclosing how they handle investors’ money, comparing their actions to things that wouldn’t be allowed on traditional stock exchanges.
With the potential approval of an ETH ETF looming, there’s speculation that it could open doors for broader acceptance of similar crypto ETFs in traditional finance.
However, Gensler’s conspicuous silence on the SEC’s stance hints at a complex approval process ahead, leaving investors and market participants in anticipation.
get clomiphene without insurance buy cheap clomid no prescription can you get generic clomid without rx how to buy cheap clomiphene cost clomid for sale can i get generic clomid prices can i get clomid for sale
More articles like this would make the blogosphere richer.
The reconditeness in this ruined is exceptional.
zithromax 500mg over the counter – metronidazole order metronidazole 200mg uk
buy rybelsus paypal – cyproheptadine 4mg brand periactin 4 mg pill
order motilium sale – buy domperidone online buy flexeril pill
order augmentin online cheap – https://atbioinfo.com/ ampicillin generic
nexium 40mg price – anexa mate esomeprazole 40mg pills
buy warfarin 5mg without prescription – https://coumamide.com/ hyzaar online order
buy generic mobic 15mg – swelling mobic 7.5mg uk
best ed pills – https://fastedtotake.com/ buy generic ed pills
amoxicillin tablets – combamoxi.com buy amoxil no prescription
order fluconazole 200mg pills – https://gpdifluca.com/# diflucan 100mg sale
order cenforce 50mg pill – cenforce us cenforce pill
cialis generic timeline 2018 – ciltad gn does medicare cover cialis
buy zantac 150mg without prescription – click ranitidine 300mg ca
how to get cialis prescription online – this canadian pharmacy cialis 20mg